BodyGuard Microset With Female Luer, REF: A120-160XPSN
Published July 22, 2020 · Recall initiated: June 16, 2020
Summary
FDA records medical device Class I recall Z-2588-2020, published July 22, 2020 and initiated June 16, 2020. Recalling firm: CME America, LLC; Status: Terminated; Reported quantity: 50; Lot: All lots within expiry. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- CME America, LLC
- Distributor
- U.S: CA, IN, LA, MO, FL, IL, ME, MN, CO, VA, OK, NE, GA, AL, KY, IA, MS, ID, TX, SC, OH, SD, NV, MI, WY, NC, PA, TN, KS, NJ, OR, AR, NM, MA, NY, DC, RI, MD, WA, WI, AZ, NH, UT, HI, AK, MT, ND, VT, CT. OUS (Foreign): Canada, UK
- Lot
- All lots within expiry
- Risk classification
- Class I
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDACME America T-Syringe Pump - T34L PCA - Product Usage: infusion of medications or fluids requiring continuousDecember 9, 2020
- FDACME America T-Syringe Pump - T34 - Product Usage: infusion of medications or fluids requiring continuous orDecember 9, 2020
- FDABodyGuard Microset, REF: A120-160X2YBJuly 22, 2020
- FDABodyGuard Microset, REF: A120-161XPSJuly 22, 2020
- FDABodyGuard Microset with Filter and Manual Priming Valve, REF: A120-112XSFVJuly 22, 2020
- FDABodyGuard Microset w/ 0.2 mic filter and lower y-site with female luer, REF: A120-160CYFRVJuly 22, 2020
Questions about this recall
Was BodyGuard Microset With Female Luer, REF: A120-160XPSN recalled?
Yes. FDA published recall Z-2588-2020 on July 22, 2020. Reported hazard: Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
What should I do if I have this product?
Voluntary: Firm initiated · Letter